142 related articles for article (PubMed ID: 35778350)
41. Production by human squamous cell carcinoma of a factor inducing activation and proliferation of immune cells.
Hirabayashi H; Yasumura S; Lin WC; Amoscato A; Johnson JT; Herberman RB; Whiteside TL
Arch Otolaryngol Head Neck Surg; 1995 Mar; 121(3):285-92. PubMed ID: 7873144
[TBL] [Abstract][Full Text] [Related]
42. Ovarian cancer-derived copy number alterations signatures are prognostic in chemoradiotherapy-treated head and neck squamous cell carcinoma.
Essers PBM; van der Heijden M; Vossen D; de Roest RH; Leemans CR; Brakenhoff RH; van den Brekel MWM; Bartelink H; Verheij M; Vens C
Int J Cancer; 2020 Sep; 147(6):1732-1739. PubMed ID: 32167160
[TBL] [Abstract][Full Text] [Related]
43. Natural killer cell mediated cytotoxicity of tumor cells initiated by neem leaf preparation is associated with CD40-CD40L-mediated endogenous production of interleukin-12.
Bose A; Baral R
Hum Immunol; 2007 Oct; 68(10):823-31. PubMed ID: 17961770
[TBL] [Abstract][Full Text] [Related]
44. Boosting Natural Killer Cell-Mediated Targeting of Sarcoma Through DNAM-1 and NKG2D.
Sayitoglu EC; Georgoudaki AM; Chrobok M; Ozkazanc D; Josey BJ; Arif M; Kusser K; Hartman M; Chinn TM; Potens R; Pamukcu C; Krueger R; Zhang C; Mardinoglu A; Alici E; Temple HT; Sutlu T; Duru AD
Front Immunol; 2020; 11():40. PubMed ID: 32082316
[TBL] [Abstract][Full Text] [Related]
45. Therapeutic potential of highly cytotoxic natural killer cells for gastric cancer.
Mimura K; Kamiya T; Shiraishi K; Kua LF; Shabbir A; So J; Yong WP; Suzuki Y; Yoshimoto Y; Nakano T; Fujii H; Campana D; Kono K
Int J Cancer; 2014 Sep; 135(6):1390-8. PubMed ID: 24615495
[TBL] [Abstract][Full Text] [Related]
46. Anti-tumor effects of NK cells and anti-PD-L1 antibody with antibody-dependent cellular cytotoxicity in PD-L1-positive cancer cell lines.
Park JE; Kim SE; Keam B; Park HR; Kim S; Kim M; Kim TM; Doh J; Kim DW; Heo DS
J Immunother Cancer; 2020 Aug; 8(2):. PubMed ID: 32830112
[TBL] [Abstract][Full Text] [Related]
47. Up-regulation of NK cell function against head and neck cancer in response to ss-isRNA requires TLR7.
Pries R; Wulff S; Kesselring R; Börngen K; Xie L; Wollenberg B
Int J Oncol; 2008 Nov; 33(5):993-1000. PubMed ID: 18949362
[TBL] [Abstract][Full Text] [Related]
48. Inhibition of NK cell activity through TGF-beta 1 by down-regulation of NKG2D in a murine model of head and neck cancer.
Dasgupta S; Bhattacharya-Chatterjee M; O'Malley BW; Chatterjee SK
J Immunol; 2005 Oct; 175(8):5541-50. PubMed ID: 16210663
[TBL] [Abstract][Full Text] [Related]
49. High-efficient generation of natural killer cells from peripheral blood with preferable cell vitality and enhanced cytotoxicity by combination of IL-2, IL-15 and IL-18.
Liu M; Meng Y; Zhang L; Han Z; Feng X
Biochem Biophys Res Commun; 2021 Jan; 534():149-156. PubMed ID: 33309274
[TBL] [Abstract][Full Text] [Related]
50. Distribution of circulating natural killer cells and T lymphocytes in head and neck squamous cell carcinoma.
Böttcher A; Ostwald J; Guder E; Pau HW; Kramp B; Dommerich S
Auris Nasus Larynx; 2013 Apr; 40(2):216-21. PubMed ID: 22835730
[TBL] [Abstract][Full Text] [Related]
51. Fc-engineered anti-CD33 monoclonal antibody potentiates cytotoxicity of membrane-bound interleukin-21 expanded natural killer cells in acute myeloid leukemia.
Mani R; Rajgolikar G; Nunes J; Zapolnik K; Wasmuth R; Mo X; Byrd JC; Lee DA; Muthusamy N; Vasu S
Cytotherapy; 2020 Jul; 22(7):369-376. PubMed ID: 32303428
[TBL] [Abstract][Full Text] [Related]
52. Comparison of the composition of lymphocyte subpopulations in non-relapse and relapse patients with squamous cell carcinoma of the head and neck before, during radiochemotherapy and in the follow-up period: a multicenter prospective study of the German Cancer Consortium Radiation Oncology Group (DKTK-ROG).
Niu M; Combs SE; Linge A; Krause M; Baumann M; Lohaus F; Ebert N; Tinhofer I; Budach V; von der Grün J; Rödel F; Grosu AL; Multhoff G
Radiat Oncol; 2021 Jul; 16(1):141. PubMed ID: 34332614
[TBL] [Abstract][Full Text] [Related]
53. Expanded natural killer cells augment the antimyeloma effect of daratumumab, bortezomib, and dexamethasone in a mouse model.
Thangaraj JL; Ahn SY; Jung SH; Vo MC; Chu TH; Thi Phan MT; Kwon M; Lee KH; Kim M; Song GY; Yang DH; Ahn JS; Kim HJ; Cho D; Lee JJ
Cell Mol Immunol; 2021 Jul; 18(7):1652-1661. PubMed ID: 33980993
[TBL] [Abstract][Full Text] [Related]
54. Natural killer cell-based adoptive immunotherapy eradicates and drives differentiation of chemoresistant bladder cancer stem-like cells.
Ferreira-Teixeira M; Paiva-Oliveira D; Parada B; Alves V; Sousa V; Chijioke O; Münz C; Reis F; Rodrigues-Santos P; Gomes C
BMC Med; 2016 Oct; 14(1):163. PubMed ID: 27769244
[TBL] [Abstract][Full Text] [Related]
55. The Synergistic Use of IL-15 and IL-21 for the Generation of NK Cells From CD3/CD19-Depleted Grafts Improves Their
Heinze A; Grebe B; Bremm M; Huenecke S; Munir TA; Graafen L; Frueh JT; Merker M; Rettinger E; Soerensen J; Klingebiel T; Bader P; Ullrich E; Cappel C
Front Immunol; 2019; 10():2816. PubMed ID: 31849984
[TBL] [Abstract][Full Text] [Related]
56. Intensified NK cell therapy in combination with low-dose chemoradiotherapy against human colorectal cancer.
Nguyen HPQ; Bae WK; Park MS; Chung IJ; Nam TK; Jeong JU; Uong TNT; Cho D; Kim SK; Yoon M
Cancer Immunol Immunother; 2023 Dec; 72(12):4089-4102. PubMed ID: 37801126
[TBL] [Abstract][Full Text] [Related]
57. North-South Divide: Chemo-Immunotherapy Combination in Head and Neck Squamous Cell Cancer (HNSCC).
Boon IS; Boon CS; Oguejiofor K; Ramkumar S
Clin Oncol (R Coll Radiol); 2024 Jun; 36(6):e169. PubMed ID: 38565459
[No Abstract] [Full Text] [Related]
58. CHK1/2 Inhibitor Prexasertib Suppresses NOTCH Signaling and Enhances Cytotoxicity of Cisplatin and Radiation in Head and Neck Squamous Cell Carcinoma.
Zeng L; Nikolaev A; Xing C; Della Manna DL; Yang ES
Mol Cancer Ther; 2020 Jun; 19(6):1279-1288. PubMed ID: 32371584
[TBL] [Abstract][Full Text] [Related]
59. Gene expression profiling of circulating natural killer cells in head and neck squamous cell carcinoma.
Böttcher A; Ostwald J; Koczan D; Knecht R; Kramp B; Dommerich S
Cancer Genomics Proteomics; 2013; 10(5):197-207. PubMed ID: 24136972
[TBL] [Abstract][Full Text] [Related]
60. Expansion of NK Cells Using Genetically Engineered K562 Feeder Cells.
Phan MT; Lee SH; Kim SK; Cho D
Methods Mol Biol; 2016; 1441():167-74. PubMed ID: 27177665
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
